IFP Advisors, Inc

Position in HLN — Haleon plc

CIK 1641866 TAMPA, FL

Position in HLN

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$47,497

+$9,090 QoQ

Shares Held

4,745

+24.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

IFP Advisors, Inc holds $7,125,146 across 42 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	142,344	$4,287,401
2	ZTS	Zoetis Inc.	9,273	$1,096,161
3	UTHR	UNITED THERAPEUTICS Corp	1,545	$916,154
4	NBIX	Neurocrine Biosciences Inc	2,792	$367,818
5	CTOR	Citius Oncology, Inc.	107,424	$66,602
6	ALKS	Alkermes plc.	1,398	$49,433
7	HLN	Haleon plc This page	4,745	$47,497
8	TLRY	Tilray Brands, Inc.	5,513	$35,669

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$47,497	4,745	+24.9%	Shares	Sole	2026-04-13
2025-12-31	$38,407	3,799	+19.0%	Shares	Sole	2026-02-06
2025-09-30	$28,632	3,192	-21.7%	Shares	Sole	2026-02-06
2025-06-30	$42,288	4,078	+7.1%	Shares	Sole	2025-07-24
2025-03-31	$39,174	3,807	-52.1%	Shares	Sole	2025-05-05
2024-12-31	$75,852	7,951	+8.9%	Shares	Sole	2025-02-04
2024-09-30	$77,255	7,302	-33.7%	Shares	Sole	2025-02-04
2024-06-30	$90,934	11,009	+15.2%	Shares	Sole	2024-07-30
2024-03-31	$81,164	9,560	-6.9%	Shares	Sole	2024-07-30
2023-12-31	$84,497	10,267	+5.3%	Shares	Sole	2024-01-09
2023-09-30	$81,250	9,754	+67.2%	Shares	Sole	2023-10-12
2023-06-30	$48,872	5,832	-19.6%	Shares	Sole	2023-08-14
2023-03-31	$59,055	7,255	-58.9%	Shares	Sole	2023-04-18
2022-12-31	$141,264	17,658	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.